{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:05Z","timestamp":1793059985366,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T00:00:00Z","timestamp":1473120000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Magnus Bergvalls Foundation"},{"name":"Kaolinska Institutet"},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s12020-016-1088-1","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T14:46:34Z","timestamp":1473173194000},"page":"618-624","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists"],"prefix":"10.1007","volume":"55","author":[{"given":"Sunita M.C.","family":"De Sousa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Torpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,6]]},"reference":[{"issue":"12","key":"1088_CR1","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"A.F. Daly, M. Rixhon, C. Adam, A. Dempegioti, M.A. Tichomirowa, A. Beckers, High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769\u20134775 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"1088_CR2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community\u2010based, cross\u2010sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. (Oxf.) 72(3), 377\u2013382 (2010)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"1088_CR3","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1210\/jc.2003-030979","volume":"89","author":"A Colao","year":"2004","unstructured":"A. Colao, G. Vitale, P. Cappabianca, F. Briganti, A. Ciccarelli, M. De Rosa, S. Zarrilli, G. Lombardi, Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J. Clin. Endocrinol. Metab. 89(4), 1704\u20131711 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1088_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"M.P. Gillam, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27(5), 485\u2013534 (2006)","journal-title":"Endocr. Rev."},{"issue":"4","key":"1088_CR5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1023\/A:1025377816769","volume":"5","author":"L Sibal","year":"2002","unstructured":"L. Sibal, P. Ugwu, P. Kendall-Taylor, S.G. Ball, R.A. James, S.H. Pearce, K. Hall, R. Quinton, Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary 5(4), 243\u2013246 (2002)","journal-title":"Pituitary"},{"issue":"9","key":"1088_CR6","first-page":"3053","volume":"85","author":"JJ Pinzone","year":"2000","unstructured":"J.J. Pinzone, L. Katznelson, D.C. Danila, D.K. Pauler, C.S. Miller, A. Klibanski, Primary medical therapy of micro-and macroprolactinomas in men. J. Clin. Endocrinol. Metab. 85(9), 3053\u20133057 (2000)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"14","key":"1088_CR7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"J. Webster, G. Piscitelli, A. Polli, C.I. Ferrari, I. Ismail, M.F. Scanlon, A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N. Engl. J. Med. 331(14), 904\u2013909 (1994)","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"1088_CR8","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","volume":"84","author":"J Verhelst","year":"1999","unstructured":"J. Verhelst, R. Abs, D. Maiter, A. van den Bruel, M. Vandeweghe, B. Velkeniers, J. Mockel, G. Lamberigts, P. Petrossians, P. Coremans, C. Mahler, A. Stevenaert, J. Verlooy, C. Raftopoulos, A. Beckers, Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J. Clin. Endocrinol. Metab. 84(7), 2518\u20132522 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"1088_CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.genhosppsych.2007.05.004","volume":"29","author":"DJ Vinkers","year":"2007","unstructured":"D.J. Vinkers, N.J. van der Wee, A case of mania after long-term use of quinagolide. Gen. Hosp. Psychiatry 29(5), 464 (2007)","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"12","key":"1088_CR10","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"T.J. Moore, J. Glenmullen, D.R. Mattison, Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern. Med. 174(12), 1930\u20131933 (2014)","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"1088_CR11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11102-015-0636-7","volume":"18","author":"CD Andela","year":"2015","unstructured":"C.D. Andela, M. Scharloo, A.M. Pereira, A.A. Kaptein, N.R. Biermasz, Quality of life (QoL) impairments in patients with a pituitary adenoma: a systematic review of QoL studies. Pituitary 18(5), 752\u2013776 (2015)","journal-title":"Pituitary"},{"issue":"2","key":"1088_CR12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/jc.2003-030852","volume":"89","author":"M Rosa De","year":"2004","unstructured":"M. De Rosa, S. Zarrilli, G. Vitale, C. Di Somma, F. Orio, L. Tauchmanova\u2019, G. Lombardi, A. Colao, Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence. J. Clin. Endocrinol. Metab. 89(2), 621\u2013625 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1088_CR13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"I. Bancos, M.R. Nannenga, J.M. Bostwick, M.H. Silber, D. Erickson, T.B. Nippoldt, Impulse control disorders in patients with dopamine agonist\u2010treated prolactinomas and nonfunctioning pituitary adenomas: a case\u2013control study. Clin. Endocrinol. (Oxf.) 80(6), 863\u2013868 (2014)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"1088_CR14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1530\/EJE-12-0198","volume":"167","author":"AP Athanasoulia","year":"2012","unstructured":"A.P. Athanasoulia, C. Sievers, M. Ising, A.C. Brockhaus, A. Yassouridis, G.K. Stalla, M. Uhr, Polymorphisms of the drug transporter gene ABCB1 predict side effects of treatment with cabergoline in patients with PRL adenomas. Eur. J. Endocrinol. 167(3), 327\u2013335 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1088_CR15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11102-013-0480-6","volume":"17","author":"M Barake","year":"2014","unstructured":"M. Barake, A.E. Evins, L. Stoeckel, G.N. Pachas, L.B. Nachtigall, K.K. Miller, B.M. Biller, N.A. Tritos, A. Klibanski, Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study. Pituitary 17(2), 150\u2013156 (2014)","journal-title":"Pituitary"},{"issue":"5","key":"1088_CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","volume":"34","author":"J Martinkova","year":"2011","unstructured":"J. Martinkova, L. Trejbalova, M. Sasikova, J. Benetin, P. Valkovic, Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clin. Neuropharmacol. 34(5), 179\u2013181 (2011)","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"1088_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5694\/j.1326-5377.2009.tb02289.x","volume":"190","author":"H Falhammar","year":"2009","unstructured":"H. Falhammar, J.Y. Yarker, Pathological gambling and hypersexuality in cabergoline-treated prolactinoma. Med. J. Aust. 190(2), 97 (2009)","journal-title":"Med. J. Aust."},{"key":"1088_CR18","unstructured":"A. Gupta, R.S. Zimmerman: Hypersexuality in cabergoline-treated prolactinoma. Paper presented at the 93rd Annual Meeting of the Endocrine Society, 2011"},{"key":"1088_CR19","unstructured":"M.R. Nannenga, P.J. Tebben, T.B. Nippoldt: Development of impulse control disorders in patients with dopamine agonist treated prolactinomas: a case series. Paper presented at the 93rd Annual Meeting of the Endocrine Society, 2011"},{"issue":"3-4","key":"1088_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00207458708987147","volume":"37","author":"R Sandyk","year":"1987","unstructured":"R. Sandyk, M. Bergsneider, R.P. Iacono, Acute psychosis in a woman with a prolactinoma. Int. J. Neurosci. 37(3\u20134), 187\u2013190 (1987)","journal-title":"Int. J. Neurosci."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-1088-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-1088-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T20:49:16Z","timestamp":1657226956000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-1088-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1088"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-1088-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,6]]}}}